U. Michigan launches DNA diagnostic nonprofit; Varian and Intuitive Surgical spar over market share;

 @FierceMedDev: Is Boston Sci still reeling from its $28B purchase of Guidant? More | Follow @FierceMedDev

 @MarkHFierce: Mission accomplished: Sunshine Heart closes public offering of common stock and pulls in $18 million. Item | Follow @MarkHFierce

 @DamianFierce: Regulus has signed on with Biogen Idec to develop microRNA diagnostics for MS. News | Follow @DamianFierce

> The University of Michigan has partnered with the International Genomics Consortium to develop a nonprofit joint venture to develop DNA diagnostics and pursue personalized medicine. More

> Thermo Fisher Scientific ($TMO) is selling debt to help fund its $925 million deal to buy diagnostics firm One Lambda, an acquisition announced last month. News

> Poiesis Medical is launching the Duette urinary catheter, a device it says reduces the risk of bladder trauma present in competing techs. Item

> Alfa Wassermann is now marketing its ACE Axcel clinical chemistry system, a diagnostic interface designed to speed up in-office lab testing. Story

> The battle for market share in robot-assisted surgeries puts Varian Medical ($VAR) against Intuitive Surgical ($ISRG). Article

> Cardiorespiratory diagnostics company Angeion is changing its name and stock symbol. From here on, the firm is called MGC Diagnostics Corporation and trades under $MGCD. Release

Biotech News

 @FierceBiotech: IMS bags planning tech for clinical trials with TTC buyout. News | Follow @FierceBiotech

 @JohnCFierce: Idenix shares eviscerated as clinical hold raises tox fears. Article | Follow @JohnCFierce

 @RyanMFierce: I'm planning a trip to visit my biotech neighbors to the north in Montreal. Looking forward to putting faces to names and so forth. | Follow @RyanMFierce

> Novartis eye drug prevails in PhIII trials ahead of FDA action. News

> Upbeat PhIII results bolster Medivation's big plans for enzalutamide. Story

> Regulus notches another microRNA deal in pact with Biogen Idec. More

> Promising colitis data build blockbuster case for Pfizer's tofacitinib. Story

Pharma News

 @FiercePharma: Maybe K-V Pharma should have listened to Facebook as the Makena pricing furor grew: More | Follow @FiercePharma

> Guess who's coming to dinner, Howard? More

> Abbott's CEO paycheck bigger than its tax bill, study says. Article

> U.K. docs don't see sales reps, and don't use pharma's websites, either. News

Vaccines News

> Antigen Discovery receives $2.5M grant for malaria vax. Item

> Heart disease vaccine steps closer. Report

> Feds cut Ebola vax funding. More

> FDA approves 6 flu vaccines. Story

Pharma Manufacturing News

> It is overfilled pain drug in latest Hospira recall. News

> Morphotek turns to manufacturing with new plant. Story

> West-Ward plant problems undermine Hikma earnings. Article

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.